Response to Letter to the Editor: Post-Vaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease

J Pediatr Gastroenterol Nutr. 2023 Jun 1;76(6):e90. doi: 10.1097/MPG.0000000000003760. Epub 2023 Mar 12.

Author

Affiliation

¹ From the Department of Paediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

No abstract available

Publication types

Comment

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines*
COVID-19* / prevention & control
Child
Humans
SARS-CoV-2

Substances

COVID-19 Vaccines
BNT162 Vaccine